Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 11, 2021
Reporting Period: Single event date (November 11, 2021)
Business Context: The Company is an emerging growth company incorporated in Delaware, trading on The Nasdaq Stock Market under the symbol "LUCD". This filing serves as a Regulation FD disclosure regarding a strategic business expansion.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report focused on a specific corporate event and does not contain audited financial statements or quarterly financial results.
Material Changes
- Geographic Expansion: The Company announced the launch of Lucid Test Centers in three new metropolitan areas: Denver, Salt Lake City, and Las Vegas.
- Operational Status: This expansion represents a material change in the Company's operational footprint as of the report date.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release (Exhibit 99.1) detailing the expansion but does not include specific forward-looking guidance, financial projections, or management discussion on future performance within the text of the 8-K itself.
Risks and Contingencies: The filing text does not explicitly list new risks or contingencies associated with the expansion, nor does it detail unusual items. The information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the operational status and capacity of the new test centers in Denver, Salt Lake City, and Las Vegas.
- Review the attached press release (Exhibit 99.1) for specific details on the timeline and investment required for this expansion.
- Check subsequent filings (e.g., 10-Q or 10-K) for the financial impact of this expansion on revenue and operating expenses.
- Confirm the Company's continued status as an emerging growth company and its implications for financial reporting standards.